Oxygen4Life, with a valuation of $5 million, is elevating funds on DealMaker Securities. It’s a biomedicine firm that leverages its partnerships with patents for individuals affected by an impaired delta-6 desaturase metabolic pathway. The medical meals of Oxygen4Life, EXtrek, manages illnesses together with heart problems, diabetes, neuropathy, IBS, fatty liver, and extra. Mike Maunu based Oxygen4Life in February 2022. The present crowdfunding marketing campaign has a minimal goal of $10,000 and a most goal of $500,400. The marketing campaign proceeds can be used for advertising and marketing, options enhancement, operations, and hiring.
The submit Oxygen4Life on DealMaker Securities 2023 appeared first on KingsCrowd.
